Inactive Instrument

Nimutan AB (publ) Stock

Equities

NIMU

SE0001789793

Food Processing

Dynamic Chart
Nimutan AB agreed to Spin-Off 1.6% stake in Humble Group AB (OM:HUMBLE). CI
Nimutan AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Nimutan AB Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
MedicaNatumin AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Medicanatumin AB Publ Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
MedicaNatumin AB Reports Earnings Results for the Full Year Ended December 31, 2020 CI
MedicaNatumin AB acquired Vitalkost AS for NOK 26 million. CI
Medica Clinical Nord Holding AB Reports Consolidated Earnings Results for the Six Months Ended June 30, 2017 CI
TJ Gruppen AB and JOOL Invest AB cancelled the acquisition of 11.77% stake in Medica Clinical Nord Holding AB from QV Private Equity AB. CI
Medica Clinical Nord Holding AB (NGM:MCNH MTF) acquired Natumin Pharma AB for SEK 31.5 million. CI
TJ Gruppen AB and JOOL Invest AB agreed to acquire 11.77% stake in Medica Clinical Nord Holding AB from QV Private Equity AB. CI
The founders acquired an additional 3.36% stake in Medica Clinical Nord Holding AB from QV Private Equity AB. CI
Scandinavian Clinical Nutrition i Sverige AB completed the acquisition of Medica Clinical Nord AB from QV Private Equity AB, Bengt Johansson, Karl-Olov Eriksson and others. CI
Scandinavian Clinical Nutrition i Sverige AB signed an agreement to acquire Medica Clinical Nord AB from QV Private Equity AB, Bengt Johansson, Karl-Olov Eriksson and others. CI
More news
Managers TitleAgeSince
Chief Executive Officer - 20-12-31
Director of Finance/CFO 38 -
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 63 19-12-31
Founder - 05-11-24
Director/Board Member 74 16-04-30
More insiders
Nimutan AB (publ), formerly MedicaNatumin AB is a Sweden-based healthcare products company that develops and manufactures dietary supplements, medical devices and dermatological and cosmetic products. The Company's series consist of documented products in men's and women's health, general health and skin care. The products fall into the categories of dietary supplements, medical technology and dermatological and cosmetic products. The brands include dietary supplements such as L-Argiplex and Nypozin and the scientifically documented skin care series Jabushe. The Company also has the distribution rights for dietary supplements such as Astaxin, Ester-C and Kyolic. Nimutan AB is certified according to Svensk Egenvard's system for safe dietary supplements for consumers.
More about the company